Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Junshi Biosciences Announces Acceptance of the Supplemental New Drug Application of Toripalimab (Subsutaneous Injection) for the 1st-Line Treatment of HER2-Expressing Urothelial Carcinoma
-
Activity Report for Quarter Ended September 30, 2026 (Appendix 4C)
-
Lithium, Location & Long-Term Vision: Elektros INC. (OTC:ELEK) Eyes an American Supply-Chain Opportunity
-
Velocity Capital Group's Jay Avigdor Announces Book Pre-Orders and Upcoming Podcast "Chewing Glass"
-
Velocity Capital Group's Jay Avigdor Announces Book Pre-Orders and Upcoming Podcast "Chewing Glass"
-
HYRT Micro-Irrigation Delivers Global Field Success with Durable, High-Efficiency Agricultural Solutions
-
Study confirms FireFly on track to be a significant copper producer
-
Samjung Advances Steel Production Board Performance Through Material Technology Engineered for Concrete Production
-
Ming Sing Floral Water to Make U.S. Debut at 2026 USA Taiwan Global Expo
-
VeriSilicon Introduces GLTiny™ 3D GPU Programming Model for Ultra-Low-Power, Memory-Efficient Wearable Devices
-
Renesas Announces Consolidated Forecasts
-
Renesas Reports Financial Results for the Third Quarter Ended September 30, 2026
-
Pacific Life Re Strengthens Market Leadership to Support Client Growth
-
HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Primary Immune Thrombocytopenia
-
The Next Chapter in American Lithium: Elektros (OTC:ELEK) Spotlights a Potential New York Opportunity
-
FuriosaAI Secures $620 Million Series D to Meet Surging Enterprise AI Inference Demand and Accelerate Next-Gen Silicon
-
Professionals’ Financial - Mutual Funds Inc. announces a change to the management of FDP Canadian Equity Portfolio
-
The Inner Circle acknowledges David R. Neff, DO as a Pinnacle Lifetime Member
-
Nexera Announces Closing of Final Tranche of its Private Placement of Units (under Partial Revocation Order)
-
Guidewire Congratulates 2026 Innovation Award Winners - Beazley, Definity, and RCIS
-
Arizona Attorney General Kris Mayes Supports Independent Examination of South32 Hermosa Mining Project Water Impacts
-
Allied Announces Third-Quarter Results
-
Ascletis' Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted HbA1c Reduction of 1.7% at 12 Weeks from Its U.S. Phase II Study in Participants with Diabetes
-
America's Lithium Future Takes Center Stage: Elektros (OTC:ELEK) Explores a New York Opportunity
-
F3 Announces Grant of Stock Options and Restricted Share Units
-
Hemophilia B Market Size in the 7MM is projected to grow at a CAGR of 8.4% over the forecast period of 2026-2036 | DelveInsight
-
Metastatic HER2 Positive Breast Cancer Market Size in the 7MM is projected to grow at a significant CAGR over the forecast period of 2026-2036 | DelveInsight
-
Chondrosarcoma Market Size in the 7MM is projected to grow at a 16% CAGR over the forecast period of 2026-2036 | DelveInsight
-
Diabetic Retinopathy Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
-
Encephalopathy Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
-
Influenza A Market Size in the 7MM is projected to reach ~USD 10,000 million by 2036, growing at a CAGR of 7.9% during 2026-2036 | DelveInsight
-
Dry Eye Disease Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
-
Cannabinoid Agonist Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
-
Anaplastic Lymphoma Kinase-positive Non-Small Cell Lung Cancer Market is Projected to Grow by 2036 Owing to the Advancement of Novel Targeted Therapies | DelveInsight
-
Adult Myopia Market is Projected to Grow by 2036 Owing to the Rising Prevalence and Development of Novel Therapies | DelveInsight
-
Acute Pancreatitis Market is Projected to Grow by 2034 Owing to the Development of Novel Therapies | DelveInsight
-
Charcot Marie Tooth Disease Clinical Trial Pipeline Gains Momentum: 13+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
-
CALIFORNIA SCIENCE CENTER UNVEILS SAMUEL OSCHIN AIR AND SPACE CENTER WITH 100 INTERACTIVE EXHIBITS AND RARE ARTIFACTS
-
The Inner Circle acknowledges Dr. Michael M. Pennock, MD, MBiot, DABR, as a Pinnacle Lifetime Member
-
DXP Enterprises, Inc. Announces New Share Repurchase Program
-
Arizona Attorney General Kris Mayes Supports Independent Examination of South32 Hermosa Mining Project Water Impacts
-
Autoimmune Uveitis Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
-
Waldenstrom Macroglobulinemia Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
-
Cluster Headache Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
-
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
-
5W Named to Inc.'s Power Partner Awards, Recognizing Leading Service Providers
-
PEComa Market Size is projected to grow at a CAGR of 8.1% over the forecast period of 2026-2036 | DelveInsight
-
Search2light Solutions Embeds with Grimes Carbon Technologies to Accelerate Commercialization
-
North America Home Finance Inc. Financial Results for the Year Ended June 30, 2026
-
Beyond Underwriting: The Growing Role of Risk Management in P&C Insurance
